XORTX Therapeutics Inc.: XORTX Announces Update for Discussion with the FDA
Type B Meeting Discussion to Accelerate XRx-026 for Gout to NDA CALGARY, Alberta, March 19, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ: XRTX | TSXV: XRTX | Fra ...
XORTX Announces Update for Discussion with the FDA
Type B Meeting Discussion to Accelerate XRx-026 for Gout to NDA ● CALGARY, Alberta, March 19, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics ...
Rheumatology Advisor5d
The Challenges of Diagnosing Seronegative Rheumatic Diseases
Credit: Dr Salahuddin Kazi, MD, comments on the challenges of diagnosing seronegative rheumatic diseases and discusses a ...
Pope Francis resting after suffering from two acute breathing crises
Pope Francis delivers his blessing during his weekly general audience in the Pope Paul VI hall at the Vatican, Wednesday, Feb. 5, 2025. (AP Photo/Andrew Medichini) ...
Endocrinology Advisor15d
Pegloticase Therapy for Uncontrolled Gout Shows Low Cardiovascular Event Risks
Pegloticase therapy for uncontrolled gout does not appear to significantly increase the risk for cardiovascular (CV) or thromboembolic (TE) events, despite the potential for increased gout flares ...
rmdopen.bmj15d
Spontaneous resolution of acute gout: mechanisms and therapeutic targets
Onset of gout is related to the deposition of monosodium urate crystals under hyperuricaemia. Interestingly, acute gout attacks often resolve spontaneously within 7–10 days, and many studies have ...
BMJ15d
Neutrophil microvesicles resolve gout by inhibiting C5a-mediated priming of the inflammasome
Objectives Gout is a highly inflammatory but self-limiting joint disease induced by the precipitation of monosodium urate (MSU) crystals. While it is well established that inflammasome activation by ...
gut.bmj15d
Acute-on-chronic liver failure: an update
clinic.cat; pgines{at}clinic.ub.es Acute-on-chronic liver failure (ACLF) is a syndrome characterised by acute decompensation of chronic liver disease associated with organ failures and high short-term ...
ANI Pharmaceuticals Announces FDA Approval of New Purified Cortrophin Gel® Prefilled Syringe
ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced U.S. Food and Drug Administration (FDA) approval of Purified Cortrophin® Gel (repository corticotropin injection USP) ...
Castanet20d
Dealing with the painful effects of gout
The acute form of gout usually begins suddenly without warning. Seventy percent of attacks involve the big toe, although other joints, including in the ankle, foot, foot, knee, wrist and elbow can ...
BioSpace22d
XORTX Commences Gout Program NDA Discussions with the FDA
[PubMed: 28122760] About XORTX Therapeutics Inc. XORTX is a pharmaceutical company with three clinically advanced products in development: 1) our lead program XRx-026 program for the treatment of gout ...